Jury Tells Amgen To Pay $20.2M In Antibody Patent Trial
A Delaware federal jury decided Friday that Amgen Inc. and its Teneobio Inc. unit willfully infringed a mouse antibody patent asserted by Harbour Antibodies BV and others, and should pay $20.2...To view the full article, register now.
Already a subscriber? Click here to view full article